HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (3- iodophenoxy)- 6,7- diethoxyquinazoline

structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - 4-(3-iodophenoxy)-6,7-diethoxyquinazoline: 2

Experts

1.	Hirata, Masahiko: 2 articles (06/2013 - 06/2012)
2.	Kagawa, Shinya: 2 articles (06/2013 - 06/2012)
3.	Kanai, Yasukazu: 2 articles (06/2013 - 06/2012)
4.	Matsumuro, Keiji: 2 articles (06/2013 - 06/2012)
5.	Naka, Sadahiro: 2 articles (06/2013 - 06/2012)
6.	Ohmomo, Yoshiro: 2 articles (06/2013 - 06/2012)
7.	Yoshimoto, Mitsuyoshi: 2 articles (06/2013 - 06/2012)
8.	Katsuma, Hideyuki: 1 article (06/2013)
9.	Magata, Yasuhiro: 1 article (06/2013)
10.	Yamaguchi, Hiroshi: 1 article (06/2013)

Related Diseases

1.

Neoplasms (Cancer)

06/01/2013 - "Previously, radioiodinated 4-(3-iodophenoxy)-6,7-diethoxyquinazoline (PHY) was reported to possess good characteristics as a tumor imaging agent. "
06/01/2012 - "To improve the in vivo stability, m-IPQ derivatives, 4-(3-iodophenoxy)-6,7-diethoxyquinazoline (PHY) and 4-(3-iodobenzylamino)-6,7-diethoxyquinazoline (BAY) were designed and synthesized, and the biological studies of [(125)I]PHY and [(125)I]BAY were performed to evaluate these new ligands as in vivo tumor diagnosis agents. "

Related Drugs and Biologics

1.	Ligands
2.	4- (3- iodobenzylamino)- 6,7- diethoxyquinazoline